Theravance Biopharma Inc Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 17.7M | 45.9M | 20.0M | 26.2M | 15.4M | 18.8M | 16.9M | 14.3M |
| Cost of Goods Sold | 1.4M | 1.5M | 8.1M | 10.5M | 11.5M | 9.5M | 9.3M | 10.0M |
| Gross Profit | 16.3M | 44.4M | 11.9M | 15.7M | 3.9M | 9.3M | 7.6M | 4.3M |
| R&D Expenses | 5.8M | 7.0M | 8.1M | 10.5M | 11.5M | 9.4M | 9.3M | 10.0M |
| Operating Expenses | 24.6M | 26.8M | 18.3M | 18.4M | 18.4M | 18.5M | 18.4M | 20.0M |
| Operating Income | -8.3M | 17.6M | -6.5M | -2.7M | -14.4M | -9.2M | -10.8M | -15.7M |
| Other Income / Gains | 1.8M | 55.5M | 3.6M | 75.9M | 296K | 261K | 785K | 484K |
| Net Income | -4.9M | 61.0M | 3.6M | 54.8M | -13.6M | -15.5M | -12.7M | -16.5M |
| EPS (Diluted) | -0.096 | 1.20 | 0.07 | 1.09 | -0.27 | -0.31 | -0.26 | -0.34 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.919 | 0.967 | 0.594 | 0.60 | 0.256 | 0.496 | 0.451 | 0.302 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 14.2M | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 4.3M | 0 | 0 |
| Selling General And Administrative Expenses | 17.7M | 19.9M | 0 | 0 | 0 | 18.5M | 0 | 0 |
| Other Expenses | 1.0M | 0 | 10.2M | 7.9M | 6.9M | -9.4M | 9.2M | 10.1M |
| Cost And Expenses | 26.0M | 28.3M | 26.4M | 28.9M | 29.8M | 28.0M | 27.7M | 30.0M |
| Interest Income | 0 | 0 | 4.1M | 1.5M | 939K | 904K | 1.4M | 1.1M |
| Interest Expense | 0 | 583K | 573K | 663K | 643K | 643K | 630K | 644K |
| Depreciation And Amortization | 1.4M | 1.5M | 409K | 409K | 413K | 695K | 429K | 427K |
| Ebitda | -5.0M | 75.2M | -1.9M | 74.3M | -13.1M | -7.6M | -8.8M | -12.3M |
| Ebitdaratio | -0.284 | 1.638 | -0.095 | 2.836 | -0.85 | -0.405 | -0.524 | -0.865 |
| Operating Income Ratio | -0.469 | 0.383 | -0.323 | -0.104 | -0.938 | -0.491 | -0.642 | -1.102 |
| Income Before Tax | -6.5M | 73.1M | -2.9M | 73.2M | -14.1M | -8.9M | -10.1M | -15.2M |
| Income Before Tax Ratio | -0.366 | 1.592 | -0.145 | 2.795 | -0.919 | -0.477 | -0.596 | -1.068 |
| Income Tax Expense | -1.5M | 12.0M | -6.5M | 18.4M | -559K | 6.6M | 2.6M | 1.3M |
| Net Income Ratio | -0.279 | 1.33 | 0.181 | 2.093 | -0.882 | -0.828 | -0.753 | -1.159 |
| Epsdiluted | -0.096 | 1.15 | 0.07 | 1.08 | -0.27 | -0.31 | -0.26 | -0.34 |
| Weighted Average Shs Out | 51.3M | 50.9M | 50.5M | 50.2M | 49.7M | 49.3M | 49.0M | 48.7M |
| Weighted Average Shs Out Dil | 51.3M | 53.1M | 51.9M | 50.7M | 49.7M | 49.3M | 49.0M | 48.7M |